🔎 Trials Near Me

Beranda › Obesitas › Texas › Dallas

Uji klinis Obesitas di Dallas, TX

30 studi untuk Obesitas mencari peserta di lokasi sekitar Dallas (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Menerima peserta
  • Baylor Scott & White Institute for Research, Dallas
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06003686

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Menerima pesertaFase 3
  • UT Southwestern Med Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • North Texas Endocrine Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Menerima pesertaFase 3
  • UT Southwestern Med Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Velocity Clinical Res-Dallas, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • Velocity Clinical Research, Dallas, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Menerima pesertaFase 3
  • UT Southwestern Medical Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • dan 2 lainnya
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • FutureSearch Trials of Dallas, Dallas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Menerima pesertaFase 3
  • Cedar Health Research, LLC, Dallas
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Menerima pesertaFase 3
  • Velocity Clinical Research, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Menerima pesertaFase 3
  • Cedar Health Research, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Menerima pesertaFase 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Cedar Health Research, LLC, Dallas
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Menerima pesertaFase awal 1Sukarelawan sehat diterima
  • University of Texas Southwestern Medical Center, Dallas
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT04838678

Effects of Obesity in the Aged

Menerima pesertaSukarelawan sehat diterima
  • Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources, Dallas
Usia 65 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05028309

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Menerima pesertaFase 2
  • University of Texas, Southwestern, Dallas
Usia 7 hingga 25 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Menerima pesertaFase 3
  • Renal Disease Research Institute, Dallas
  • Texas Health Heart and Vascular Specialists, Dallas
  • Southwest Family Medicine_Dallas, Dallas
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Menerima pesertaFase 3
  • Mercy Family Clinic, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Menerima pesertaFase 2
  • Velocity Clinical Research Dallas, Dallas
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07477704

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Menerima peserta
  • University of Texas Southwestern Medical Center, Dallas
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06924177

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

Menerima pesertaSukarelawan sehat diterima
  • UT Southwestern Medical Center, Dallas
Usia 55 hingga 90 · Semua jenis kelamin · Diperbarui 7 Mei 2026 · NCT05723679

Leg Heating in Pregnant Women With Obesity

Menerima pesertaSukarelawan sehat diterima
  • UT Southwestern Medical Center; Institute for Exercise and Environmental Medicine, Dallas
Usia 18 hingga 45 · Wanita · Diperbarui 17 Apr 2026 · NCT06932250

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Menerima peserta
  • University of Texas Southwestern, Children's Health, Dallas
Usia 6 hingga 14 · Semua jenis kelamin · Diperbarui 30 Mar 2026 · NCT07342855

Healthy Living BEYOND Weight Study

Menerima pesertaStudi observasional
  • American Heart Association, Dallas
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2025 · NCT07075341

Uji klinis Obesitas di kota lain

Studi lain di Dallas

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.